secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001493152-23-038669
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience reports FY2023 net loss of $4.0M, revenue up slightly; Q4 revenue jumps 49% YoY
--------------------------------------------------------------------------------

- Net product sales $1.871M vs $1.813M prior year (+3.2%); net loss widened to $4.0M from $3.5M.
- Cash used in operations increased to $3.3M from $2.5M; net loss per share unchanged at ($0.04).
- Q4 revenue increased 49% YoY; CEO sees turning point and confirms new customer-driven programs.
- Company moving to all-remote work model, closing Rancho Cucamonga facility to reduce costs.
- Introduced 'PURE GENIUS' food safety solution at IAFP conference; now in multiple food processing facilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223038669/0001493152-23-038669-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223038669/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038669

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer